• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Blood Donation and Improved Cardiometabolic Health

December 2, 2025

Excess stored iron can lead to health complications including insulin resistance and cardiometabolic problems. Excess stored iron may also be removed through blood donations. Researchers in Spain randomized 89 overweight (BMI>25 kg/m2) and hypercholesterolemic (190 mg/dL) but otherwise healthily blood donors with normal iron stores (median age, 55 years; 34% female) to a standard whole blood donation (n=45; 450 mL blood withdrawn) or a simulated blood donation (n=44; 6 mL blood withdrawn). After two weeks, the change from baseline for both ferritin and hemoglobin was still within the normal range, but a greater decline in the whole donation group compared to the simulated donation was observed (-21.6 µg/mL and -1.06 g/dL, respectively). In addition, glucose and insulin plasma concentrations decreased in the whole donation group but not in the simulated group. Fat oxidation only decreased in the whole donation group, but no significant changes were observed in circulating lipids or triglycerides. Further research is needed to determine whether regular blood donations may improve the long-term cardiometabolic health of individuals.

Reference:

Mora-Gonzalez D, Moreno-Cabañas A, Gonzalez García L, Cobo-Cuenca AI, et al. A standard blood bank donation improves cardiometabolic health of donors: A double-blind randomised controlled trial. Br J Haematol. 2025 Nov 27. doi: 10.1111/bjh.70270. Epub ahead of print. PMID: 41309453.

Filed Under

  • Blood Donation
  • News

Recommended

  • Nipocalimab Delays Intrauterine Transfusions for Severe Hemolytic Disease of the Fetus and Newborn

  • Liberal versus Restrictive Transfusion Strategy for Patients with Traumatic Brain Injury and Anemia

  • Erythroid Enhancer of BCL11A Gene May Determine Fetal Hemoglobin Levels

Show Comments

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Blood Donation and Improved Cardiometabolic Health

  • Mitochondrial DNA Acts as a “First Hit” for Antibody-Mediated TRALI

  • Liberal or Restrictive Transfusion Thresholds for Surgery Patients with High Cardiac Risk

  • Iron Supplementation for Blood Donors Based on Ferritin Levels

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley